GOSS
Price
$1.24
Change
-$0.03 (-2.36%)
Updated
Jun 13, 03:07 PM (EDT)
Capitalization
288.67M
60 days until earnings call
VIR
Price
$5.19
Change
-$0.03 (-0.57%)
Updated
Jun 13, 02:21 PM (EDT)
Capitalization
725.75M
48 days until earnings call
Interact to see
Advertisement

GOSS vs VIR

Header iconGOSS vs VIR Comparison
Open Charts GOSS vs VIRBanner chart's image
Gossamer Bio
Price$1.24
Change-$0.03 (-2.36%)
Volume$1.5K
Capitalization288.67M
Vir Biotechnology
Price$5.19
Change-$0.03 (-0.57%)
Volume$5.5K
Capitalization725.75M
GOSS vs VIR Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. VIR commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and VIR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (GOSS: $1.27 vs. VIR: $5.22)
Brand notoriety: GOSS and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 68% vs. VIR: 61%
Market capitalization -- GOSS: $288.67M vs. VIR: $725.75M
GOSS [@Biotechnology] is valued at $288.67M. VIR’s [@Biotechnology] market capitalization is $725.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $352B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 6 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 6 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both GOSS and VIR are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а +0.79% price change this week, while VIR (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.03%. For the same industry, the average monthly price growth was +20.17%, and the average quarterly price growth was +6.87%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 12, 2025.

VIR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($726M) has a higher market cap than GOSS($289M). GOSS YTD gains are higher at: 40.394 vs. VIR (-28.883). GOSS has higher annual earnings (EBITDA): -39.97M vs. VIR (-598.69M). VIR has more cash in the bank: 802M vs. GOSS (295M). VIR has less debt than GOSS: VIR (96.1M) vs GOSS (203M). GOSS has higher revenues than VIR: GOSS (115M) vs VIR (14.3M).
GOSSVIRGOSS / VIR
Capitalization289M726M40%
EBITDA-39.97M-598.69M7%
Gain YTD40.394-28.883-140%
P/E RatioN/AN/A-
Revenue115M14.3M804%
Total Cash295M802M37%
Total Debt203M96.1M211%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSVIR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSMBX15.820.02
+0.13%
Tributary Small/Mid Cap Instl Plus
PRMTX165.36N/A
N/A
T. Rowe Price Comm & Tech Investor
MLPFX9.06N/A
N/A
Invesco SteelPath MLP Select 40 A
CGTRX10.57N/A
N/A
Columbia Select Large Cap Growth Inst2
TLOFX9.42N/A
N/A
Transamerica Large Value Opps R4